The Valley Desk

NCT00280865 · Interventional trial

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

Overall registry status Completed

Phase 2

Conditions Type 2 Diabetes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov